Safety of conventional systemic therapies for psoriasis on reproductive potential and outcomes.

Zenas Z N Yiu, Richard B Warren, Ulrich Mrowietz, Christopher E M Griffiths

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The effects of conventional systemic therapies for psoriasis on pregnancy outcomes, lactation, male fertility and mutagenicity are common concerns in the clinical setting. There is relatively little evidence to guide clinician and patient. In this study, we review the safety profile of the commonly used conventional systemic therapies used for psoriasis in individuals of reproductive potential. Safety data are derived from large-scale registries, adverse-event reporting databases, clinical trials and case reports. We assess the effect of each therapy on adverse pregnancy outcomes, including congenital malformations, and lactation with maternal administration. We also assess the effect of the therapies on male fertility and potential mutagenicity with paternal administration. We provide applicable guidance to inform clinician and patient before and after conception.
    Original languageEnglish
    JournalThe Journal of dermatological treatment
    Volume26
    Issue number4
    DOIs
    Publication statusPublished - 2015

    Keywords

    • Acitretin
    • ciclosporin
    • fumaric acid esters
    • methotrexate
    • pregnancy

    Fingerprint

    Dive into the research topics of 'Safety of conventional systemic therapies for psoriasis on reproductive potential and outcomes.'. Together they form a unique fingerprint.

    Cite this